SCHEMBL339681

SCHEMBL339681

O=C1N=NC2C1=Cc1ccccc12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17337956 0.70 ALDH1A1 (0.31)
SCHEMBL10382285 0.70
SCHEMBL8011185 0.63 ALDH1A1 (0.46)
SCHEMBL30031817 0.63 CYP11B1 (0.36)
SCHEMBL647672 0.63
SCHEMBL852350 0.62 EDNRB (0.33)
Hydrochloric Acid SCHEMBL6448210 0.62
Hydrochloric Acid SCHEMBL645056 0.62
SCHEMBL11052520 0.62 POLB (0.40)
Hydrochloric Acid SCHEMBL4068961 0.62 CYP11B1 (0.34)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8097619-B2 Inhibitors of cyclin-dependent kinases, compositions and uses related thereto AGENNIX USA INC. (US) 2012-01-17 US disclosed
US-7893057-B2 Inhibitors of cyclin-dependent kinases, compositions and uses related thereto AGENNIX USA INC. (US) 2011-02-22 US disclosed
US-7786112-B2 Inhibitors of cyclin-dependent kinases, compositions and uses related thereto AGENNIX USA INC. (US) 2010-08-31 US disclosed
US-20100004207-A1 Inhibitors of cyclin-dependent kinases, compositions and uses related thereto GPC BIOTECH INC. 2010-01-07 US disclosed
US-7605175-B2 Inhibitors of cyclin-dependent kinases, compositions and uses related thereto GPC BIOTECH AG (DE) 2009-10-20 US disclosed
US-20090209530-A1 INHIBITORS OF CYCLIN-DEPENDENT KINASES, COMPOSITIONS AND USES RELATED THERETO GPC BIOTECH, INC. (US) 2009-08-20 US disclosed
EP-1832589-A1 Inhibitors of cyclin-dependent kinases,compositions and uses related thereto GPC Biotech Inc. (US) 2007-09-12 EP disclosed
EP-1709051-A1 INHIBITORS OF CYCLIN-DEPENDENT KINASES, COMPOSITIONS AND USES RELATED THERETO GPC Biotech Inc. (US) 2006-10-11 EP disclosed
EP-1611136-A2 INHIBITORS OF CYCLIN-DEPENDENT KINASES, COMPOSITIONS AND USES RELATED THERETO GPC Biotech Inc. (US) 2006-01-04 EP disclosed
WO-2005063765-A1 INHIBITORS OF CYCLIN-DEPENDENT KINASES, COMPOSITIONS AND USES RELATED THERETO GPC BIOTECH, INC. (US) 2005-07-14 WO disclosed
US-20050090471-A1 Inhibitors of cyclin-dependent kinases, compositions and uses related thereto GPC BIOTECH, INC (US) 2005-04-28 US disclosed
US-20040266854-A1 Inhibitors of cyclin-dependent kinases, compositions and uses related thereto GPC BIOTECH, INC. (US) 2004-12-30 US disclosed
US-20040266853-A1 Inhibitors of cyclin-dependent kinases, compositions and uses related thereto GPC BIOTECH, INC. (US) 2004-12-30 US disclosed
WO-2004092139-A2 INHIBITORS OF CYCLIN-DEPENDENT KINASES, COMPOSITIONS AND USES RELATED THERETO GPC BIOTECH, INC. (US) 2004-10-28 WO disclosed
EP-1446405-A2 INHIBITORS OF CYCLIN-DEPENDENT KINASES, COMPOSITIONS AND USES RELATED THERETO GPC Biotech Inc. (US) 2004-08-18 EP disclosed
US-6753329-B2 1,5-DIHYDROPYRAZOLO(3,4-D)PYRIMIDIN-4-ONE DERIVATIVES USEFUL FOR TRATING CANCER, TUMOR AND HYPERPROLIFERATIVE DISORDERS IN ANIMALS GPC BIOTECH INC. 2004-06-22 US disclosed
US-20030162797-A1 Inhibitors of cyclin-dependent kinases, compositions and uses related thereto GPC BIOTECH AG (DE) 2003-08-28 US disclosed
WO-2003033499-A2 INHIBITORS OF CYCLIN-DEPENDENT KINASES, COMPOSITIONS AND USES RELATED THERETO GPC BIOTECH INC. (US) 2003-04-24 WO disclosed